Moreover, the EVs derived form MSCs treated with SLE serum expressed higher levels of CD9 and CD63 and lower levels of TSG101 than those derived from MSCs treated with FBS (Fig. 1G). The gene discussed is TSG101; the disease is systemic lupus erythematosus.